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Abstract
Background:  Pseudomonas aeruginosa frequently colonizes and is responsible for severe ventilator-
associated pneumonia in intubated patients. A quorum-sensing (QS) circuit, depending on the production
of the two QS-signaling molecules (autoinducers, AIs) 3-oxo-C12-HSL and C4-HSL, regulates the
production by P. aeruginosa of several virulence factors and is required for biofilm formation. Therefore
QS-inhibition has been suggested as a new target for preventive and/or therapeutic strategies. However
the precise role of QS during colonization and subsequent infections of intubated patients remains unclear.
Results: We wondered whether QS is active during colonization of intubated patients, and whether P.
aeruginosa isolates growing inside the biofilm covering the intubation devices and those resident in the
lungs of colonized patients differ in their QS-dependent phenotypes. We collected the intubation devices
of eight patients colonized by P. aeruginosa. We detected 3-oxo-C12-HSL on eight, and C4-HSL on six of
these devices. In three of these patients we also obtained P. aeruginosa isolates from tracheal aspirates at
the time of extubation (n = 18), as well as isolates from the intubation devices (n = 25). We genotyped
these isolates, quantified their AIs production, and determined three QS-dependent phenotypes
(adherence capacity, biofilm and elastase production). The production of 3-oxo-C12-HSL was consistently
increased for isolates from the intubation devices, whereas the production of C4-HSL was significantly
higher for isolates from tracheal aspirates. Isolates from tracheal aspirates produced significantly higher
amounts of elastase but less biofilm, and had a marginally reduced adhesion capacity than isolates from the
intubation devices. Levels of 3-oxo-C12-HSL and elastase production correlated statistically for tracheal
intubation isolates, whereas levels of 3-oxo-C12-HSL production and adhesion ability, as well as biofilm
production, correlated weakly amongst intubation device isolates.
Conclusion:  Our findings demonstrate that autoinducers are produced during the colonization of
intubated patients by P. aeruginosa. The microenvironment, in which P. aeruginosa grows, may select for
bacteria with different capacities to produce autoinducers and certain QS-dependent phenotypes. QS-
inhibition might therefore affect differently isolates growing inside the biofilm covering intubation devices
and those resident in the lungs.
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Background
Pseudomonas aeruginosa is an opportunistic pathogen
implicated in a wide variety of infections, particularly in
burn victims, cancer patients and cystic fibrosis (CF)
patients. In addition P. aeruginosa is a major cause of
severe pneumonia in mechanically ventilated patients [1].
Such ventilator-associated pneumonia (VAP) are almost
always preceded by the colonization of the upper respira-
tory tract. The presence of the intubation device is a major
risk factor for this colonization [2]. As such the capacities
of P. aeruginosa to adhere to the inert surface and grow
inside a biofilm on the intubation device are thought to
be essential for the subsequent colonization and infection
of the lower respiratory tract [3].
After colonizing the respiratory tract of intubated patients,
P. aeruginosa causes infections and extensive damage to
host tissues via the production of a number of extracellu-
lar virulence factors [4]. The expression of several of these
factors is controlled by a quorum-sensing (QS) circuitry
involving at least two autoinducers (AIs): N-(3-oxodo-
decanoyl)-Homoserine Lactone (3-oxo-C12-HSL) and N-
butyryl-L-Homoserine Lactone (C4-HSL) [4]. The produc-
tion of 3-oxo-C12-HSL and C4-HSL requires the autoin-
ducer synthases encoded by the lasI  and  rhlI  genes,
respectively. These QS-systems were first described for
their role in the regulation of extracellular virulence fac-
tors [5,6] but have recently been shown to regulate many
other bacterial functions including biofilm formation [7-
10].
The importance of a functional QS-circuit for the viru-
lence of P. aeruginosa has been clearly established in vivo
in animal models [11]. As a consequence QS-inhibition
has been suggested as a potential target for new preventive
and/or therapeutic strategies of P. aeruginosa infections.
However the precise role during human infections
remains speculative. Most studies so far have focused on
the capacity of clinical isolates to produce the two autoin-
ducers and on the detection of the two AIs directly in clin-
ical samples. P. aeruginosa isolates from CF patients
produce AIs in vitro [12], and sputum of CF patients colo-
nized by P. aeruginosa produces the same signals ex vivo
[13]. AIs have also been detected in situ in CF lung tissue
[14], in the sputum of CF patients [15,16], and in bron-
choalveolar lavage fluid after lung transplantation [17].
Recently we observed that most strains initially colonizing
intubated patients are QS-proficient [18]. Both 3-oxo-C12-
HSL and C4-HSL have also been detected in biofilms, both
in vivo and  in situ [15,16,19]; moreover their relative
abundance has been suggested as a marker for the biofilm
mode of growth in CF patients [13].
Because much remains to be understood about the role of
QS during human infections, and the potential of QS-
inhibition in their prevention and/or treatment, we exam-
ined the behavior of QS during the colonization of intu-
bated patients. To determine whether QS is active during
the colonization of intubated patients, we first extracted
and quantified AIs directly from the intubation devices of
patients colonized with P.aeruginosa. Because of the mul-
titude of phenotypes depending on QS we then wondered
whether P. aeruginosa isolates growing in different micro-
environments might vary in their capacity to produce AIs
and differ in their expression of QS-dependent pheno-
types. We therefore collected P. aeruginosa isolates from
the surface of intubation devices and from tracheal aspi-
rates obtained from the same patients on the day of extu-
bation. For each patient, we grouped strains according to
their genotype, and characterized them in terms of pro-
duction of autoinducers, and capacity to adhere to PVC,
and produce elastase and biofilm. Our results suggest that
the relative production of autoinducers, and the QS-
dependent phenotypes of P. aeruginosa vary according to
their site of isolation.
Results
Study population
Patients' clinical characteristics are presented in Table 1.
Underlying diseases included polytrauma, intra-cerebral
hemorrhage, congestive heart failure and non-pseudomo-
nal sepsis. Duration of mechanical ventilation ranged
from 9 to 24 days. Detailed clinical characteristics are pro-
vided for the three patients from whom P. aeruginosa iso-
lates were collected both from the intubation device and
from a tracheal aspirate on the day of extubation:
Patient 8 was a 27-year-old male who suffered a severe
polytrauma including cerebral contusion and hemor-
rhage. P. aeruginosa was cultured for the first time from his
tracheal aspirates 7 days after his intubation. Therapeutic
retreat was decided after 15 days of mechanical ventila-
tion and he died without having received any antibiotics.
The presence of P. aeruginosa in his tracheal aspirates was
considered as colonization. The tracheal aspirate used in
the present study was collected shortly before his death
and extubation.
Patient 12 was a 21-year-old female who suffered a severe
polytrauma including a cranio-cerebral trauma with dif-
fuse axonal lesions and multiple rib fractures. P. aerugi-
nosa  was first cultured in bronchoalveolar lavage fluid
four days after her intubation. P. aeruginosa pneumonia
was diagnosed two days later and she was treated with an
imipenem – tobramycin combination therapy. The clini-
cal response was satisfying and she was extubated 3 days
later still on antimicrobial therapy. A tracheal aspirate was
obtained on the day of extubation.BMC Microbiology 2007, 7:33 http://www.biomedcentral.com/1471-2180/7/33
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Patient 13 suffered severe congestive heart failure with a
cardiac arrest. P. aeruginosa was first cultured from a tra-
cheal aspirate three days after her intubation. P. aeruginosa
pneumonia was treated with cefepime during 10 days
starting 6 days after intubation. She remained colonized
by  P. aeruginosa and was extubated after 17 days of
mechanical ventilation.
In situ quantification of autoinducers on intubation 
devices
The cuff of each endotracheal intubation device was
removed and autoinducers were extracted from the bio-
film as described in Materials and Methods. 3-oxo-C12-HSL
was detected on all cuffs, the amounts varying between
0.4 and more than 10 nmoles per cuff (Table 1). C4-HSL
was detected on six of the eight devices tested and its
amount varied between 17 and 300 nmoles per cuff
(Table 1). The in situ isolation of autoinducers from bio-
films of the majority of the intubation devices suggests
that QS might play a role during colonization by P. aeru-
ginosa of such devices. The fact that we detected C4-HSL
only from 6 devices could result from the lower sensitivity
of our C4-HSL bioassay (2 nmoles/cuff) compared to the
one used to quantify 3-oxo-C12-HSL (0.01 nmoles/cuff).
Collection of P. aeruginosa isolates colonizing the 
intubation devices and the lungs of intubated patients
For the three patients in whom we obtained tracheal aspi-
rates (TA) at the time of extubation we also collected P.
aeruginosa isolates directly from the cuff of the intubation
device (ID) as described in Material and Methods. The
complete collection consisted of 18 TA isolates and 25 ID
isolates partitioned as shown in Table 2. Genotyping of
these strains by RAPD identified 4 different genotypes (B,
C, D and P). Genotypes C (3 isolates from patient 12 and
1 isolate from patient 13) and P (3 isolates from patient
13) were only found in tracheal aspirates and were there-
fore excluded from the analyses described in the following
paragraphs, when not otherwise stated. The final collec-
tion therefore consisted of 11 TA and 25 ID isolates repre-
senting genotype B (8 TA and 21 ID isolates) and
genotype D (3 TA and 4 ID isolates) (Table 2).
Phenotypic characterization of TA and ID P. aeruginosa 
isolates
(i) In vitro autoinducer production
We extracted and quantified the two autoinducers from
culture supernatants of TA and ID isolates. All isolates
produced both autoinducers in vitro, though levels varied
according to the site of isolation (Table 2). Figure 1A and
1B show the mean production of both AIs for the isolates
obtained from TA and ID for each individual patient. For
the three patients ID isolates consistently produced higher
amounts of 3-oxo-C12-HSL than TA isolates (Fig. 1A).
When all the ID isolates were compared to the TA isolates
the mean production of 3-oxo-C12-HSL was increased in
the ID group (1.6 × 10-6M; Standard Error [SE], 4.8 × 10-
7M), compared to the TA group (4.0 × 10-7M; SE, 7.4 × 10-
8M, p = 0.12) without reaching statistical significance,
possibly due to the small sample size. In contrast the TA
isolates of all patients produced higher amounts of C4-
HSL than the ID isolates (Fig. 1B), and the mean C4-HSL
concentration was significantly higher for the TA isolates
group (1.2 × 10-5 M; SE, 1.7 × 10-6M) than for the ID iso-
lates group (3.1 × 10-6M; SE, 5.4 × 10-7M; p = 0.04). Inter-
estingly all isolates (including genotypes C and P),
whatever their site of collection, produced higher levels of
C4-HSL than of 3-oxo-C12-HSL. The mean of the C4-HSL/
3-oxo-C12-HSL ratios was 38.5 for the TA group compared
to 5.1 for the ID group (p = 0.002; Fig. 1C). Excluding the
TA isolates with genotype C and P did not affect these
results significantly. Therefore the relative amounts of AIs
produced in vitro were significantly different between TA
and ID isolates. The fact that all P. aeruginosa isolates
tested were QS-proficient, i.e. able to produce both AIs in
vitro, supports a role for QS during late stages of coloniza-
tion of intubated patients both in the biofilm formed on
intubation devices and in the lung.
(ii) Production of QS-dependent virulence factors
To further characterize the P. aeruginosa isolates, we deter-
mined their in vitro production of three virulence factors
that depend upon an active QS-circuitry, namely, elastase,
protease, and rhamnolipids [4]. We assayed the produc-
tion of proteases and rhamnolipids using semi-quantita-
Table 1: Patient characteristics and intubation devices
Patient Underlying disease Duration of intubation 
(days)
Tracheal aspirate on day of extubation 3-oxo-C12-HSL 
(nmoles/cuff)
C4-HSL 
(nmoles/cuff)
2 Polytrauma 9 no 0.4 100
5 Nonpseudomonal sepsis 13 no 0.5 17
7 Intra-cerebral hemorrhage 24 no > 10 22
8 Polytrauma 15 yes > 10 22
11 Polytrauma 18 no > 10 300
12 Polytrauma 9 yes > 10 2
13 Congestive heart failure 17 yes > 10 2
14 Polytrauma 16 no 6 24BMC Microbiology 2007, 7:33 http://www.biomedcentral.com/1471-2180/7/33
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tive plate assays. Important fluctuations in the production
of rhamnolipids were observed (Table 2). This finding
was not surprising as we had previously found fluctua-
tions among QS-associated phenotypes occurring during
the colonization of intubated patients [18]. LasB elastase
is the most potent elastase produced by P. aeruginosa and
is one of the major virulence factors controlled by QS [4].
We quantified the in vitro elastase production of the clini-
cal isolates by means of the Elastin Congo Red assay at the
same point in the growth curve (early stationary phase) as
for determination of AIs production. For each patient the
isolates obtained from the TA displayed higher elastolytic
activities than those obtained from the ID (Fig. 2A). When
the isolates were grouped by site of isolation, the mean
elastase production was higher in the TA group (0.57; SE,
0.02) than in the ID group (0.23; SE, 0.02; p < 0.001; Fig.
Table 2: Characterization of P. aeruginosa isolates from intubated patients
Isolates Patients Genotype Site of Isolation Productionc of Elastasea
(OD495/OD660)
Productiona of Adhesiona (%) Biofilma (%)
Proteases Rhamnolipids 3-oxo-C12-HSL (μM) C4-HSL (μM)
61G3d 8 D TA + + + BDb 0.5 0.51 15 88 31
61E8 8 D TA + + + BD 0.59 0.41 24 88 11
60A3d 8 B TA + + + + 0.68 0.33 7.8 100 13
60B5 8 D TA + + + BD 0.65 0.36 5 139 33
63E8 8 B ID + + + + 0.3 1.3 2.4 116 83
63E9 8 B ID + + + + + 0.34 2.5 1.1 111 105
63E11d 8 B ID + + + + + + 0.29 0.19 2.9 105 89
63G3 8 B ID + + + + 0.24 0.63 15 115 59
63G6 8 D ID + + + BD 0.3 0.36 3 120 98
63G8 8 B ID + + + + + 0.2 0.21 3.3 106 125
63H2 8 B ID + + + + + + 0.12 2.7 2.9 137 74
62F2 8 D ID + + + BD 0.32 0.37 3.1 99 10
62F3d 8 D ID + + + + 0.22 0.17 2.4 101 20
62G3 8 D ID + + + BD 0.3 0.29 3.3 110 25
54A7 12 C TA + + + + + 0.5 0.36 30 104 59
54A8 12 B TA + + + + 0.63 0.41 19 115 49
54A9 12 C TA + + + + + + 0.5 0.38 12 105 49
54B1 12 C TA + + + + 0.64 0.77 30 99 60
54D5d 12 B TA + + + + 0.48 0.35 14 116 50
54D6d 12 B TA + + + + + + 0.43 0.31 18 80 53
54E1 12 B TA + + + + + 0.72 1 7.9 121 58
55A1d 12 B ID + + BD 0.19 2.6 2.1 116 78
55A2 12 B ID + + + 0.27 1.2 1.3 122 75
55A5 12 B ID + + + + 0.26 2.5 2.8 137 102
55D2 12 B ID + + + 0.27 2 3.4 118 68
55E4 12 B ID + + + + 0.31 2.5 2.7 115 88
55F3d 12 B ID + + + + + 0.22 2.5 2.2 101 59
55G2 12 B ID + + + + 0.17 4 2 117 84
55G4 12 B ID + + + 0.19 1.3 1.6 112 103
55A6 12 B ID + + + + + 0.25 2.1 3.4 126 109
56A1 13 B TA + + + + + 0.64 0.44 6.4 85 46
59B3 13 C TA + + + + + 0.45 0.3 7.9 88 39
59B4d 13 B TA + + + + + 0.47 0.16 9.5 83 48
59A1d 13 B TA + + + + + + 0.52 0.13 9.3 99 38
59B6 13 P TA + + + + + 0.45 0.28 13.5 83 41
59C1 13 P TA + + + + + + 0.52 0.27 11.3 106 77
59C2 13 P TA + + + + 0.47 0.33 13.3 101 59
63A1 13 B ID + + + + + 0.23 1.4 1.8 114 91
63A3d 13 B ID + + + + + + 0.3 0.33 3.1 137 77
61A12d 13 B ID + + + + + + 0.15 2.6 2.2 129 90
61G12 13 B ID + + + + + 0.11 2.7 2.4 121 87
62C2 13 B ID + + + + + 0.15 2.6 3.1 121 97
62C3 13 B ID + + + + + + 0.08 1.3 3.3 143 86
a Values are mean of three independent experiments with a standard deviation of < 10%.
b BD, below detection.
c +++, high level; ++, intermediate level; +, low level.
d lasR and rhlR genes sequencedBMC Microbiology 2007, 7:33 http://www.biomedcentral.com/1471-2180/7/33
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2B). These results did not differ when all the genotypes
were included in the TA isolates group. These results sug-
gest that P. aeruginosa strains originating from the lungs of
intubated patients produce higher amounts of elastase
than isolates that were resident inside the biofilm on the
intubation device.
(iii) Adhesion and biofilm formation capacity
QS has been suggested to be involved in the formation
and differentiation of biofilms [7,8,13]. The impact of the
type of surface and medium used in biofilm formation
assays appears to influence the relationship between QS
and biofilm formation [20]. We therefore decided to
measure biofilm formation with our well-established
static system using sterile PVC coupons obtained from
intubation devices [8]. In our opinion this model simu-
lates the best the conditions found on intubation devices
in patients. Both adhesion and biofilm formation capaci-
ties were compared to the laboratory strain P. aeruginosa
PT5 (100%). For each individual patient P. aeruginosa iso-
lates recovered from the surface of the ID adhered more
efficiently than their counterparts collected from the TA
(Fig. 2C). When all the isolates were grouped by site of
isolation the mean adhesion capacity was slightly
increased in the ID group without reaching statistical sig-
nificance (118.0%; SE, 4.0%) as compared to the TA
group (101.3%; SE, 5.2%; p = 0.19; Fig. 2D). The ID iso-
lates for each patient demonstrated a greater ability to
form biofilm than their TA counterparts (Fig. 2E). This dif-
ference was statistically significant when the strains were
grouped according to their site of isolation (ID isolates:
79.3%; SE, 6.3%, TA isolates: 39.1%; SE, 9.8% p= 0.01,
Autoinducer production of P. aeruginosa isolates from tracheal aspirates and intubation devices Figure 1
Autoinducer production of P. aeruginosa isolates from tracheal aspirates and intubation devices. 3-oxo-C12-HSL 
(A) and C4-HSL (B) production by P. aeruginosa isolates recovered from tracheal aspirates (open squares, TA isolates) and intu-
bation devices (plain circles, ID isolates) of 3 colonized patients (8, 12 and 13). The production of the two autoinducers was 
determined in culture supernatants by specific bioassays. Error bars correspond to the standard errors of the means. (C) 
Ratios of AI concentrations (C4-HSL/3-oxo-C12-HSL) produced by 18 isolates recovered from tracheal aspirates and 25 iso-
lates recovered from intubation devices. The horizontal line indicates the mean of the ratios.
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Quorum-sensing dependent phenotypes of P. aeruginosa isolates from tracheal aspirates and intubation devices Figure 2
Quorum-sensing dependent phenotypes of P. aeruginosa isolates from tracheal aspirates and intubation 
devices. Elastase production (A and B), adhesion capacity (C and D) and biofilm formation (E and F) by P. aeruginosa isolates 
recovered from tracheal aspirates (open squares, TA isolates) and intubation devices (plain circles, ID isolates). Elastolytic 
activities were determined by ECR assays and expressed as the OD measured at 495 nm per unit of OD 660 nm. The adhesion 
capacities and biofilm formation were expressed as the percentage relative to the level obtained with the wild-type P. aerugi-
nosa strain PT5. (A, C and E) Results individualized for each patient (8, 12 and 13), error bars correspond to the standard 
errors of the means. (B, D and F) Mean values and variances for 11 tracheal aspirate isolates and 25 isolates recovered from 
the intubation devices. For each individual isolate the determinations were performed twice in triplicates.
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Fig. 2F). Again these results were not affected when geno-
types C and P were included in the TA group. These obser-
vations indicate that P. aeruginosa isolates originating
from the biofilm of intubation devices tend to adhere
more efficiently and have higher biofilm production
capacities than their counterparts isolated from the lungs.
Correlations between autoinducer production and 
quorum-sensing dependent phenotypes
(I) Correlations between autoinducer and elastase production
In vitro, the production of elastase is under the joint con-
trol of both the las and rhl QS-systems [4,9]. In sputum of
CF patients the expression of lasR has been correlated with
the accumulation of lasB transcripts [21]. Other investiga-
tors have described a weak correlation between the in vitro
transcription levels of lasR and lasB in 50% of environ-
mental and clinical isolates [22]. We wondered whether
the production of elastase would be correlated with the
production of autoinducers. For these analyses we
included only genotypes B and D, which were present in
both TA and ID isolates. We observed a trend for a positive
correlation between 3-oxo-C12-HSL and elastase produc-
tion for the TA group (r = 0.58; p = 0.06). This positive cor-
relation became statistically significant when genotypes C
and P were included (r = 0.63, p = 0.006; Fig. 3A). In con-
trast for ID isolates we observed a statistically significant
negative correlation between elastase and 3-oxo-C12-HSL
production (r = -0.41, p = 0.04). Furthermore, C4-HSL
production was not correlated with elastase activity, what-
ever the isolate group studied (TA isolates: r =-0.38, p =
0.25 and ID isolates: r = 0.02, p = 0.70). These results sug-
gest that the level of 3-oxo-C12-HSL is positively correlated
to elastase production for isolates from tracheal aspirates
of colonized patients, but not for P. aeruginosa isolates
from biofilms covering the intubation devices.
(II) Correlation between autoinducer production, adhesion and 
biofilm formation capacities
We then examined correlations between autoinducer pro-
duction and adhesion capacity. There was a weak, statisti-
cally not significant, correlation between 3-oxo-C12-HSL
production and adhesion capacity for isolates from the ID
group (r = 0.30, p = 0.14) (Fig. 3B). No such correlation
was found for isolates from the TA group (r = 0.33, p =
0.32), even when genotypes C and P were included in the
analysis (r = 0.30, p = 0.22). We found no correlation
between C4-HSL production and adhesion for both ID
isolates (r = 0.0; p = 0.99) and TA isolates (n = 11: r = 0.34;
p = 0.30, and n = 18: r = 0.16; p = 0.53).
Similarly we observed a weak, statistically not significant,
correlation between 3-oxo-C12-HSL and biofilm produc-
tion for isolates of the ID group (r = 0.33, p = 0.11, Fig.
3C), but not for those recovered from TA (r = 0.25, p =
0.46), even after inclusion of genotypes C and P in the
analysis (r = 0.17, P = 0.49). There was no correlation
between C4-HSL and biofilm production for the ID (r = -
0.18, p = 0.31), and TA isolates (r = -0.18, p = 0.60),
despite the inclusion of genotypes C and P (r = 0.16, p =
0.52). Together these observations suggest that the pro-
duction of 3-oxo-C12-HSL but not of C4-HSL, might be
associated with in vitro adherence and biofilm formation
capacities among isolates recovered from the biofilm on
intubation devices.
Discussion
Respiratory tract colonization of intubated patients by P.
aeruginosa is initiated by the colonization of the intuba-
tion device by bacteria either originating from the diges-
tive flora of the patient (endogenous acquisition) or
transmitted via handling of the device by health care
workers (exogenous acquisition) [23]. This colonization
requires efficient bacterial adherence to the inert surface
and the formation of a biofilm [3]. P. aeruginosa then
reach the respiratory tract either by leakage around the
cuff of the intubation device, by shearing of secretions
containing embedded bacteria from the device during the
inspiratory air flow, or by contamination and direct inoc-
ulation of the respiratory tract by suction tubes introduced
through the intubation device by health care workers [23-
25].
Both in vitro studies and animal models have suggested
that QS plays a major role in the virulence of P. aeruginosa
[11]. However in situ and in patient data concerning the
potential role of QS during colonization and infection by
P. aeruginosa in humans remain scarce. QS-activity has
been linked to the detection of P. aeruginosa AIs in the
lungs of cystic fibrosis patients [13-16], as well as in lung
transplanted patients [17]. So far studies have only shown
that most of the isolates originating from colonized intu-
bated patients are QS-proficient [18,22].
In the present study we show that the two P. aeruginosa
autoinducers, 3-oxo-C12-HSL and C4-HSL, can be detected
in situ in biofilms covering intubation devices retrieved
from patients colonized by P. aeruginosa. Moreover all P.
aeruginosa isolates collected either from these biofilms or
from tracheal aspirates produced these AIs in vitro.
Whereas 3-oxo-C12-HSL has been previously shown to
play a role in the differentiation of P. aeruginosa biofilms
[7,26], C4-HSL seems to be important during the matura-
tion stage of biofilm development [27], for the total
amount of biofilm formed [8], and for the maintenance of
biofilm architecture [28]. In our study, isolates recovered
from the biofilm of intubation devices produced higher
levels of C4-HSL than 3-oxo-C12-HSL  in vitro. Previous
observations have suggested that C4-HSL is produced in
higher quantities than 3-oxo-C12-HSL in P. aeruginosa bio-
films in the lungs of CF patients [13,14]. Singh et al. haveBMC Microbiology 2007, 7:33 http://www.biomedcentral.com/1471-2180/7/33
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Correlations between autoinducer production and quorum-sensing dependent phenotypes Figure 3
Correlations between autoinducer production and quorum-sensing dependent phenotypes. Relations between 
levels of 3-oxo-C12-HSL and elastase production by P. aeruginosa isolates recovered from tracheal aspirations (A), and adhesion 
capacity (B) as well as biofilm formation (C) by P. aeruginosa isolates recovered from intubation devices. (A) For each isolate 
the production of 3-oxo-C12-HSL and elastase was measured in aliquots taken at the same time during the growth curve, and 
plotted against each other. (B and C) For each isolate aliquots for 3-oxo-C12-HSL determinations were taken at an identical 
time during the growth curve. Adhesion capacities and biofilm formation are expressed compared to wild type strain PT5 
(100%). Each determination is the mean of two independent experiments performed in triplicate.
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even suggested that this AI ratio might serve as a biomar-
ker for the biofilm mode of growth, as the mucoid isolates
from the sputum of CF patients inverted their AI ratio
when sub-cultured in liquid medium [13]. In contrast, in
our study a higher level of C4-HSL as compared to 3-oxo-
C12-HSL was observed when isolates were grown in liquid
cultures, suggesting that this ratio is not useful as a
biomarker for biofilm growth for these isolates. None of
the isolates collected from our patients had a mucoid phe-
notype. This discrepancy could therefore be explained by
inherent differences in biofilm development patterns
between mucoid and non-mucoid strains. So far there is
no evidence that non-mucoid P. aeruginosa colonizing the
lung of intubated patients grows in biofilms. Such a
hypothesis deserves further investigations.
Autoinducers have been previously recovered from bio-
films formed on urinary tract catheters [19] and our
results show for the first time that QS-signaling molecules
are also produced in biofilms covering intubation devices.
Whether the local concentrations of AIs on the intubation
devices that we measured are physiologically relevant and
are sufficient to activate the expression of QS-dependent
genes remains speculative. However microarray analyses
have shown that QS is a continuum and that the expres-
sion of some genes is already activated even at low AI con-
centrations [9]. It is therefore likely that even low
concentrations of AIs on the intubation devices are physi-
ologically relevant.
Intriguingly, the in vitro production of both AIs varied
with the site of collection. Isolates from tracheal aspirates
produced higher levels of C4-HSL but lower levels of 3-
oxo-C12-HSL than their genotypically identical counter-
parts isolated from intubation devices, even after several
in vitro passages. This observation suggests that different
microenvironments select P. aeruginosa isolates with vari-
ous AI production capacities. Moreover the production of
elastase, and the capacity to adhere to an inert surface and
to produce a biofilm also varied with the site of isolation.
Tracheal aspirate isolates produced higher levels of
elastase, but were less able to adhere and produce biofilm
than their counter-parts recovered from intubation
devices. LasB elastase is one of the major virulence factors
controlled by the P. aeruginosa QS-circuit [4]. In vitro its
production is regulated by the QS-circuit and depends
mainly on the production of 3-oxo-C12-HSL [9,10]. LasB
elastase is believed to allow P. aeruginosa to invade sur-
rounding tissues by its broad range enzymatic activity and
to facilitate blood stream invasion by degradation of elas-
tin fibers in the lamina propria of blood vessels [4].
The observed differences in phenotypes between isolates
obtained from tracheal aspirates, compared to those from
the intubation devices, make sense. Isolates growing in
the biofilm on intubation devices might not invest energy
in producing elastase, but might be primed to adhere and
form biofilms, whereas isolates growing in the lungs
might find an advantage in producing elastase. For tra-
cheal aspirate isolates, levels of 3-oxo-C12-HSL produc-
tion correlated positively with the capacity to produce
elastase. In contrast for isolates originating from the intu-
bation device, 3-oxo-C12-HSL levels did not correlate with
elastase production, but correlated weakly with the capac-
ity to adhere and to form biofilms on inert surfaces. These
observations suggest that the previously described control
of LasR on elastase production might not apply to all iso-
lates depending on the site they were collected from. It
seems that the microenvironment on the intubation
devices selects for phenotypes that produce high levels of
3-oxo-C12-HSL but without concomitant increased
elastase production. In contrast the lower lung environ-
ment seems to select for isolates that produce less 3-oxo-
C12-HSL but with a positive control of this AI on elastase
production. Two of our patients (12 and 13) received anti-
microbial therapies during their mechanical ventilation.
We can therefore not exclude that different concentrations
of these drugs at the two sites might have selected different
phenotypes. However this seems unlikely as isolates of
patient 8 presented the same differences in phenotype in
the absence of any exposure to antimicrobial therapies.
We detected no correlations between the levels of C4-HSL
production and elastase activity, adhesion or biofilm for-
mation. Strikingly, these phenotypes remained stable for
each isolate independently of its origin even after several
in vitro passages. This suggests that mutations in specific
regulators, that affect the production of AIs and the
expression of QS-dependent phenotypes might be
selected in particular microenvironments. Indeed lasR and
rhlR mutants of P. aeruginosa strains isolated from intu-
bated patients have been previously described [18]. Such
mutations influence the bacteria capacity to produce AIs,
and are expected to affect QS-dependent phenotypes. We
therefore sequenced both lasR and rhR in 6 TA and 6 ID
isolates (Table 2). None of them harbored mutations
compared to the wild type strain PAO1 (data not shown).
This explains why all the isolates analyzed in the present
study were QS-proficient. Phenotypic variations not
linked to QS but also influencing biofilm formation have
been described in P. aeruginosa isolates from CF patients
[29]. The nature of the mutational events possibly selected
either during biofilm growth on intubation devices, or
inside the lung are presently under investigation. The
identification of these events would have major implica-
tions for our understanding of bacterial selection in spe-
cific environments and the dynamics of bacterial
populations.BMC Microbiology 2007, 7:33 http://www.biomedcentral.com/1471-2180/7/33
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QS-inhibition has been suggested as a new therapeutical
approach against P. aeruginosa infections. For instance
macrolides interfere with the production of AIs [8,30] and
were shown to retard biofilm formation [31]. Our result
might be important if QS-inhibitors that interfere with the
production and/or activity of one, or both, of the autoin-
ducers are used in the prevention or treatment of P. aeru-
ginosa VAP. Indeed, our data suggest that inhibition of QS
might have different effects on P. aeruginosa isolates
depending on their microenvironnement.
Conclusion
Our study was limited to the analysis of three patients;
therefore it is difficult to draw general conclusions from
our observations. However the results were consistent
between these patients and reached statistical significance
despite the small number. Our results showed that during
colonization of intubated patients P. aeruginosa autoin-
ducers are produced in the biofilms covering the intuba-
tion devices. The capacity to produce autoinducers and
the expression of QS-dependent phenotypes vary with the
site of isolation. Further studies will be required to inves-
tigate the mechanism that led to selection of specific phe-
notypes in a particular microenvironment directly in vivo
and to determine how this impacts the use of anti-quo-
rum-sensing strategies.
Methods
Patient population and clinical sample collection
We collected the intubation devices of eight patients
known to be colonized by P. aeruginosa and hospitalized
in the surgical intensive care service of the University Hos-
pital Geneva. All patients, except patient 14, have been
described previously (Table 1) [18]. Following extubation
the endotracheal tubes were wrapped in a sterile cloth and
transported without delay to the laboratory were they
were stored at -70°C until use. Sterile cotton swabs were
used to detach bacteria embedded in biofilm formed on
the cuff, on the exterior surface of the intubation device
(ID).  Pseudomonas  isolates were identified on selective
Cetrimide agar plates. In order to avoid compiling identi-
cal P. aeruginosa isolates, we collected individual clones
based on morphologic differences of their respective col-
ony forming units (CFU). A total of 25 ID isolates were
collected from patients 8, 12 and 13, and stored at -70°C
(Table 2).
We obtained tracheal aspirates by suctioning secretions
with a sterile tube introduced deeply inside the lower res-
piratory tract through the intubation device from three
patients (patients 8, 12 and 13) either on the day before,
or on the day of extubation. The tracheal aspirates (TA)
were plated on selective agar plates (Cetrimide 0.03%) in
order to identify Pseudomonas isolates [14]. Similarly to ID
isolates, special care was taken to select isolates with dif-
ferent morphologic phenotypes according to their CFUs.
A total of 18 different TA isolates were identified and
stored at -70°C (Table 2).
For further assays both ID and TA isolates were taken from
the frozen stocks and grown in liquid cultures.
Media and culture conditions
Cultures for extraction of cell-to-cell signaling molecules
and production of elastase were grown in Luria-Bertani
(LB) broth. M63 medium [32] was used for bacterial
adhesion assays and AP medium [33] was used for bio-
film formation assays. No differences in growth rates were
observed between the strains in these media.
Extraction and quantification of acylated homoserine 
lactones (AIs) from intubation devices and liquid cultures
Previous studies have suggested that secretions colonized
by bacteria accumulate above the cuff of intubation
devices and form biofilms [34-36]. Leakage of bacteria
around the cuff might play a major role in the develop-
ment of ventilator-associated pneumonia [25,37]. Conse-
quently, we selected the cuff of the intubation devices for
the quantification of AIs. To extract AIs; cuffs were asepti-
cally cut off the intubation devices, incubated for 30 min-
utes at 37°C in 5 ml sterile saline containing 0.025%
dithiothreitol (DTT) to resuspend the biofilms formed on
the cuff, and extracted twice by the addition of 1 volume
of acidified ethyl acetate for 5 minutes at -20°C. To extract
AIs from liquid cultures of both ID and TA isolates, the
strains were incubated in LB broth at 37°C with shaking.
Aliquots of filtered culture supernatants, taken after 8
hours of growth (early stationary phase), were subjected
to 2 extractions in 1 volume of acidified ethyl acetate and
stored at -70°C. Aliquots of the extracts obtained from the
cuffs and liquid cultures of ID and TA isolates were evap-
orated under nitrogen gas and the concentrations of 3-
oxo-C12-HSL and C4-HSL determined using the reporter
strains  E. coli MGλ1,4 (pPCS1) [38] and P.aeruginosa
PAO-JP2 (pECP61.5) [39] respectively. For each determi-
nation standard curves were obtained with the wild type
strain PAO1. The amount of AIs recovered from the intu-
bation devices was expressed as nmoles/cuff.
Determination of bacterial genotype
Bacterial strains were genotyped by Random Amplified
Polymorphic DNA (RAPD) analysis as previously
described using the Ready-to-Go Kit (Amersham) [18]
using primer 208 (ACGGCCGACC) [40].
Production of protease, rhamnolipids and elastase
Total extracellular protease [41] and rhamnolipid [42]
production of both ID and TA isolates were determined
semi-quantitatively by agar plate assays. Elastase produc-
tion was quantified using the Elastin Congo Red elastoly-BMC Microbiology 2007, 7:33 http://www.biomedcentral.com/1471-2180/7/33
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sis assay [38,41]. Culture supernatants were collected at
the same point in the bacterial growth curve as for AI
extraction.
Assessment of bacterial adhesion and biofilm formation 
assay
Adhesion capacity was measured for both ID and TA iso-
lates as the ability of bacteria to adhere to the wells of 96-
well microtiter plates. The assay was performed as previ-
ously described [18]. Results were expressed as percent
adhesion with respect to the PT5 wild type strain. The abil-
ity of bacteria to form biofilm in vitro was determined in a
static model as previously described [8]. Briefly, overnight
LB cultures of ID and TA isolates were diluted to an OD660
of 0.5 and incubated for a further 6 hours at 37°C with
shaking until cells had entered early stationary phase.
Sterile calibrated coupons of PVC tracheal tubing were
immersed in the suspension and incubated statically at
37°C for 1 h, then the PVC coupons were transferred to 6-
well cell culture plates and incubated statically at 37°C for
72 h in AP medium. The extent of biofilm formation was
measured using crystal violet staining [43]. Results were
expressed as percent biofilm formation with respect to the
PAO1 wild type strain.
Statistical analysis
We used the Student's t test to compare mean production
of AIs and virulence factors by isolates from tracheal aspi-
rates (TA) and the cuff of the intubation device (ID). Cor-
relations between AIs production and QS-dependent
phenotypes were calculated using a robust estimator of
the Pearson's correlation coefficient. To account for the
correlation among multiple observations in the same
patient, standard errors and p values were computed using
a first-order Taylor-series linearization method. All analy-
ses were conducted using Stata 6.0 statistical software
(StataCorp, 1999). p < 0.05 was considered statistically
significant.
Authors' contributions
SFB carried out the experiments and drafted the manu-
script. CE conducted the statistical analysis. TK partici-
pated in the design of the study and participated in the
analysis of the results. JAR organized the sample collec-
tion. CVD conceived the study, supervised the experi-
ments and their analysis, and wrote the final manuscript.
All authors read and approved the final manuscript.
Acknowledgements
We would like to thank J. Pugin, and B. Ricou for supplying us with the intu-
bation devices necessary for the study, P. Wood for helping during the 
preparation of the manuscript and R. Comte for technical assistance. This 
work was supported by grants from the Programme Commun de Recher-
che en Génie Biomédical, Genève, Lausanne 1999–2002 and from the Swiss 
National Science Foundation (3231–51940.97 and 3200–052189.97) to 
CVD.
References
1. Dunn M, Wunderink RG: Ventilator-associated pneumonia
caused by  Pseudomonas  infection.  Clin Chest Med 1995, 16:95.
2. Levine SA, Niederman MS: The impact of tracheal intubation on
host defenses and risks for nosocomial pneumonia.  Clin Chest
Med 1991, 12(3):523.
3. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a
common cause of persistent infections.  Science 1999,
284(5418):1318.
4. Van Delden C, Iglewski BH: Cell-to-cell signaling and  Pseu-
domonas aeruginosa  infections.  Emerg Infect Dis 1998, 4:551.
5. Latifi A, Winson MK, Foglino M, Bycroft BW, Stewart GS, Lazdunski
A, Williams P: Multiple homologues of LuxR and LuxI control
expression of virulence determinants and secondary metab-
olites through quorum sensing in  Pseudomonas aeruginosa
PAO1.  Mol Microbiol 1995, 17:333.
6. Passador L, Cook JM, Gambello MJ, Rust L, Iglewski BH: Expression
of  Pseudomonas aeruginosa  virulence genes requires cell-
to-cell communication.  Science 1993, 260(5111):1127.
7. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW,
Greenberg EP: The involvement of cell-to cell signals in the
development of bacterial biofilm.  Science 1998, 280:295.
8. Favre-Bonté S, Köhler T, Van Delden C: Biofilm formation by
Pseudomonas aeruginosa : role of the C4-HSL cell-to-cell
signal and inhibition by azithromycin   .  J Antimicrob Chemother
2003, 52:598-604.
9. Schuster M, Lostroh CP, Ogi T, Greenberg EP: Identification, tim-
ing, and signal specificity of Pseudomonas aeruginosa quo-
rum-controlled genes: a transcriptome analysis.  J Bacteriol
2003, 185(7):2066.
10. Wagner VE, Bushnell D, Passador L, Brooks AI, Iglewski BH: Micro-
array analysis of Pseudomonas aeruginosa quorum-sensing
regulons: effects of growth phase and environment.  J Bacteriol
2003, 185:2080.
11. Rumbaugh KP, Griswold JA, Hamood AN: The role of quorum
sensing in the in vivo virulence of Pseudomonas aeruginosa.
Microbes Infect 2000, 2:1721.
12. Geisenberger O, Givskov M, Riedel K, Hoiby N, Tümmler B, Eberl L:
Production of N-acyl-L-homoserine lactones by P. aerugi-
nosa isolates from chronic lung infections associated with
cystic fibrosis.  FEMS Microbiol Lett 2000, 184:273.
13. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Green-
berg EP: Quorum-sensing signals indicate that cystic fibrosis
lungs are infected with bacterial biofilms.  Nature 2000,
407:762.
14. Favre-Bonté S, Pache JC, Robert J, Blanc D, Pechère JC, Van Delden
C: Detection of Pseudomonas aeruginosa cell-to-cell signals
in lung tissue of cystic fibrosis patients.  Microb Pathog 2002,
32(3):143.
15. Erickson DL, Endersby R, Kirkham A, Stuber K, Vollman DD, Rabin
HR, Mitchell I, Storey DG: Pseudomonas aeruginosa quorum-
sensing systems may control virulence factor expression in
the lungs of patients with cystic fibrosis.  Infect Immun 2002,
70(4):1783.
16. Middleton B, Rodgers HC, Camara M, Knox AJ, Williams P, Hardman
A: Direct detection of N-acylhomoserine lactones in cystic
fibrosis sputum.  FEMS Microbiol Lett 2002, 207(1):1.
17. Ward C, Camara M, Forrest I, Rutherford R, Pritchard G, Daykin M,
Hardman A, de Soyza A, Fisher AJ, Williams P, Corris PA: Prelimi-
nary findings of quorum signal molecules in clinically stable
lung allograft recipients.  Thorax 2003, 58(5):444.
18. Denervaud V, TuQuoc P, Blanc D, Favre-Bonté S, Krishnapillai V,
Reimmann C, Haas D, Van Delden C: Characterization of cell-to-
cell signaling-deficient Pseudomonas aeruginosa strains col-
onizing intubated patients.  J Clin Microbiol 2004, 42(2):554.
19. Stickler DJ, Morris NS, McLean RJ, Fuqua C: Biofilms on indwelling
urethral catheters produce quorum-sensing signal mole-
cules in situ and in vitro .  Appl Environ Microbiol 1998, 64:3486.
20. Shrout JD, Chopp DL, Just CL, Hentzer M, Givskov M, Parsek MR:
The impact of quorum sensing and swarming motility on
Pseudomonas aeruginosa biofilm formation is nutritionally
conditional.  Mol Microbiol 2006.
21. Storey DG, Ujack EE, Rabin HR, Mitchell I: Pseudomonas aerugi-
nosa lasR transcription correlates with the transcription of
lasA, lasB, and toxA in chronic lung infections associated
with cystic fibrosis.  Infect Immun 1998, 66(6):2521.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Microbiology 2007, 7:33 http://www.biomedcentral.com/1471-2180/7/33
Page 12 of 12
(page number not for citation purposes)
22. Cabrol S, Olliver A, Pier GB, Andremont A, Ruimy R: Transcription
of quorum-sensing system genes in clinical and environmen-
tal isolates of Pseudomonas aeruginosa.  J Bacteriol 2003,
185:7222.
23. Chastre J, Fagon JY: Ventilator-associated pneumonia.  Am J
Respir Crit Care Med 2002, 165(7):867.
24. Craven DE, Steger KA: Epidemiology of nosocomial pneumo-
nia. New perspectives on an old disease.  Chest 1995, 108(2
Suppl):1S.
25. Rello J, Sonora R, Jubert P, Artigas A, Rue M, Valles J: Pneumonia in
intubated patients: role of respiratory airway care.  Am J Respir
Crit Care Med 1996, 154(1):111.
26. De Kievit TR, Gillis R, Marx S, Brown C, Iglewski BH: Quorum-
sensing genes in Pseudomonas aeruginosa biofilms: their
role and expression patterns.  Appl Environ Microbiol 2001,
67(4):1865.
27. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG: Pseu-
domonas aeruginosa displays multiple phenotypes during
development as a biofilm.  J Bacteriol 2002, 184(4):1140.
28. Davey ME, Caiazza NC, O'Toole GA: Rhamnolipid surfactant
production affects biofilm architecture in Pseudomonas aer-
uginosa PAO1.  J Bacteriol 2003, 185(3):1027.
29. Drenkard E, Ausubel FM: Pseudomonas biofilm formation and
antibiotic resistance are linked to phenotypic variation.
Nature 2002, 416(6882):740.
30. Tateda K, Comte R, Pechère JC, Köhler T, Yamaguchi K, Van Delden
C: Azithromycin inhibits quorum sensing in Pseudomonas
aeruginosa.  Antimicrob Agents Chemother 2001, 45(6):1930-1933.
31. Gillis RJ, Iglewski BH: Azithromycin retards Pseudomonas aer-
uginosa biofilm formation.  J Clin Microbiol 2004, 42(12):5842.
32. West SE, Kaye SA, Hamood AN, Iglewski BH: Characterization of
Pseudomonas aeruginosa mutants that are deficient in exo-
toxin A synthesis and are altered in expression of regA, a
positive regulator of exotoxin A.  Infect Immun 1994, 62(3):897.
33. Terry JM, Pina SE, Mattingly SJ: Role of energy metabolism in
conversion of nonmucoid Pseudomonas aeruginosa to the
mucoid phenotype.  Infect Immun 1992, 60(4):1329.
34. Mahul P, Auboyer C, Jospe R, Ros A, Guerin C, el Khouri Z, Galliez
M, Dumont A, Gaudin O: Prevention of nosocomial pneumonia
in intubated patients: respective role of mechanical subglot-
tic secretions drainage and stress ulcer prophylaxis.  Intensive
Care Med 1992, 18(1):20.
35. Inglis TJ, Millar MR, Jones JG, Robinson DA: Tracheal tube biofilm
as a source of bacterial colonization of the lung.  J Clin Microbiol
1989, 27(9):2014.
36. Inglis TJ, Lim TM, Ng ML, Tang EK, Hui KP: Structural features of
tracheal tube biofilm formed during prolonged mechanical
ventilation.  Chest 1995, 108(4):1049.
37. Valles J, Artigas A, Rello J, Bonsoms N, Fontanals D, Blanch L, Fern-
andez R, Baigorri F, Mestre J: Continuous aspiration of subglottic
secretions in preventing ventilator- associated pneumonia.
Ann Intern Med 1995, 122(3):179.
38. Pearson JP, Pesci EC, Iglewski BH: Role of  Pseudomonas aerugi-
nosa   las  and  rhl  quorum-sensing systems in the control of
elastase and rhamnolipid biosynthesis genes.  J Bacteriol 1997,
179(18):5756.
39. Van Delden C, Comte R, Bally M: Stringent response activates
quorum sensing and modulates cell density-dependent gene
expression in Pseudomonas aeruginosa.  J Bacteriol 2001,
183(18):5376.
40. Mahenthiralingam E, Campbell ME, Foster J, Lam JS, Speert DP: Ran-
dom amplified polymorphic DNA typing of Pseudomonas
aeruginosa isolates recovered from patients with cystic
fibrosis.  J Clin Microbiol 1996, 34(5):1129.
41. Van Delden C, Pesci EC, Pearson JP, Iglewski BH: Starvation selec-
tion restores elastase and rhamnolipid production in a  Pseu-
domonas aeruginosa  quorum-sensing mutant.  Infect Immun
1998, 66(9):4499.
42. Köhler T, Van Delden C, Curty LK, Hamzehpour MM, Pechère JC:
Overexpression of the MexEF-OprN multidrug efflux system
affects cell-to-cell signaling in Pseudomonas aeruginosa.  J
Bacteriol 2001, 183(18):5213-5222.
43. O'Toole GA, Kolter R: Flagellar and twitching motility are nec-
essary for Pseudomonas aeruginosa biofilm development.
Mol Microbiol 1998, 30(2):295.